Log In
BCIQ
Print this Print this
 

Xtend-TNF (XmAb6755)

  Manage Alerts
Collapse Summary General Information
Company Xencor Inc.
DescriptionAnti-TNF antibody using Xtend Fc domain technology
Molecular Target Tumor necrosis factor (TNF)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard Indication Autoimmune (unspecified)
Indication DetailsTreat autoimmune diseases
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

03/09/2009

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today